Alligator Bioscience AB Stock Deutsche Boerse AG
Stocks
7AL0
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
15:40:35 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 EUR | 0.00% |
|
0.00% | -99.55% |
| 08-28 | Redeye cuts justified value for Alligator Bioscience | FW |
| 08-26 | BioArctic fell on a slightly higher Stockholm market, OMXS30 index rose 0.2 percent | FW |
| Market Cap | 18.84M 1.96M 1.69M 1.59M 1.45M 2.73M 187M 2.74M 7.35M 94.7M 7.36M 7.2M 317M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 18.84M 1.96M 1.69M 1.59M 1.45M 2.73M 187M 2.74M 7.35M 94.7M 7.36M 7.2M 317M | EV / Sales 2026 * |
3.19x | EV / Sales 2027 * | 0.38x |
| Free-Float |
83.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Alligator Bioscience AB
| 6 months | -50.00% | ||
| Current year | -99.55% |
| 1 week | 0 |  | 0.05 |
| 1 month | 0 | | 0.05 |
| Current year | 0 | | 0.07 |
| 1 year | 0 | | 0.46 |
| 3 years | 0 | | 131.6 |
| 5 years | 0 | | 553 |
| 10 years | 0 | | 3,715 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 2021-05-31 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 2024-08-11 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 2021-05-31 | |
Denise Goode
BRD | Director/Board Member | 68 | 2022-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 1.97M | |
| -0.78% | -1.42% | +2.96% | +21.65% | 50.47B | |
| -6.00% | -0.75% | +447.48% | +535.14% | 44.56B | |
| -0.24% | +0.74% | +37.18% | +16.26% | 43.08B | |
| -1.55% | -2.07% | +19.83% | +71.70% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.79% | -3.24% | +26.32% | +125.06% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.63% | +27.62% | 14.58B | |
| -1.66% | -1.25% | +78.49% | +42.97% | 13.92B | |
| Average | -1.38% | -1.06% | +80.42% | +111.08% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.06% | +96.28% | +129.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 615K 530K 498K 454K 855K 58.57M 858K 2.3M 29.65M 2.31M 2.26M 99.24M | 49.7M 5.18M 4.47M 4.19M 3.82M 7.2M 493M 7.23M 19.38M 250M 19.43M 19M 836M |
| Net income | -15.2M -1.58M -1.37M -1.28M -1.17M -2.2M -151M -2.21M -5.93M -76.39M -5.94M -5.81M -256M | 28.9M 3.01M 2.6M 2.44M 2.22M 4.19M 287M 4.2M 11.27M 145M 11.3M 11.05M 486M |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-08-28 | €0.000100 | 0.00% |
| 26-08-27 | €0.000100 | 0.00% |
| 26-08-26 | €0.000100 | 0.00% |
| 26-08-25 | €0.000100 | 0.00% |
| 26-08-24 | €0.000100 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
- 7AL0 Stock
Select your edition
All financial news and data tailored to specific country editions
